Skip to main content
. 2024 Aug 29;16(1):2390176. doi: 10.1080/19490976.2024.2390176

Figure 8.

Figure 8.

The schematic diagram of L. acidophilus ameliorating cholestatic liver injury. L. acidophilus inhibits hepatic BAs synthesis by activating intestinal FXR signaling, and increases unconjugated BAs by enriched BSH enzymes to enhance the BAs excretion, which could attenuate cholestatic liver injury.